top of page

ULUSLARARASI DERGİ VE KİTAPLARDAKİ TAM METİN YAYINLAR 

​​

  1. Saka E., Saygı S., Ciğer A., Selekler K. Circling Seizures. Seizure 1996, 5: 299-302.
     

  2. Saka E., Elibol B., Erdem S., Dalkara T. Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment. Brain Research 1999; 825: 104-114.
     

  3. Saka E., Elibol B., Saygı S. Circling Seizures in a case with Wilson’s Disease. Clin Electroencephalogr, 1999;30: 118-121.
     

  4. Saka E., Saygı S. Familial Adult Onset Myoclonic Epilepsy associated with Migraine. Seizure (European Journal of Epilepsy) 2000; 9: 344-346.
     

  5. Saka E, Saygı S. Rotatory seizures are not as rare as described. Epileptic Disorders 2000;2:V.
     

  6. Demir E., Saka E., Aysun S. A case of Sandifer’s syndrome presented with hand tremor. Turkish Journal of Pediatrics 2001; 43:348-350.
     

  7. Saka E., Iadarola M., Fitzgerald D.J., Graybiel A.M. Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc. Natl. Acad. Sci.USA 2002; 99: 9004-9009.
     

  8. Graybiel A.M., Saka E. A genetic basis for obsessive grooming. Neuron 2002, 33:1-2.
     

  9. Saka E., Graybiel A.M. Pathophysiology of Tourette’s syndrome: Striatal pathways revisited. Brain Dev 2003; 25 (Suppl 1): S15-S19.
     

  10. Saka E., Goodrich C., Harlan P., Madras B.K., Graybiel A.M. Repetitive behaviors in monkeys are linked to specific striatal activation patterns. Journal of Neuroscience 2004; 24:7557-7565.
     

  11. Graybiel AM, Saka E. Basal Ganglia and the Control of Action. In: The Cognitive Neuroscience III, ed. Gazzaniga MS, ed). Cambridge, MA: MIT press; 2004. p. 495-510.
     

  12. Saka E. Neuropsychiatric emergencies. In: Approaches to Neurological Emergencies, eds. Fisher M and Önal MZ, S.A , Prous Science; 2005. P. 201-218, (online edition). (www.ttmed.com/dementia/books.cfm?ID_Dis=216&ID_Cou=237&ID_Book=1669&id_chapter=12315)
     

  13. Topcuoglu MA, Saka E, Onal MZ. Hyperoxia potentiated sonothrombolysis as a method of acute ischemic stroke therapy. Med Hypotheses 2006; 66 :59-65.
     

  14. Saka E., Topcuoglu M.A., Akkaya B., Galati A., Onal M.Z., Vincent A. Thymus changes in anti MuSK –positive and –negative myasthenia gravis. Neurology 2005; 65:782-783.
     

  15. Akif Topcuoglu M, Saka E. Hypothermia and sonothrombolysis. Thromb Res 2006; 118:289-90.
     

  16. Saka E., Ozkaynak S, Tuncer R. Tongue tremor in a case with brainstem pilocytic astrocytoma. Journal of Clinical Neuroscience 2006; 13: 503-506.
     

  17. Saka E, Mihci E, Topcuoglu MA, Balkan S. Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer’s disease and mild cognitive impairment in Turkish people. Arch Clin Neuropsychol 2006; 21:745-51.
     

  18. Saka E, Dogan EA, Topcuoglu MA, Senol U, Balkan S. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Arch Gerontol Geriatr 2007; 44:141-51.
     

  19. Eker A, Saka E, Dalmau J, Kurne A, Bilen C, Ozen H, Ertoy D, Oguz KK, Elibol B. Testicular Teratoma and Anti-N-methy-D-aspartate Receptor Associated Encephalitis. J Neurol Neurosurg Psychiatry 2008;79:1082-1083.
     

  20. Topcuoglu MA, Aydin H, Saka E. Occipital cortex activation studied with simultaneous recordings of functional Doppler ultrasound (fTCD) and visual evoked potential (VEP) in cognitively normal human subjects: effect of healthy aging. Neurosci Lett 2009; 452: 17-22.
     

  21. Saka E, Elibol B. Enhanced cued recall and clock drawing test performances differ in Parkinson’s and Alzheimer’s disease-related cognitive dysfunction. Parkinsonism Relat Disord 2009;15: 688-691.
     

  22. Crittenden JR, Cantuti-Castelvetri I, Saka E, Kleer-McGandy CE, Hernandez LF, Kett LR, Young AB, Standaert DG, Graybiel AM. Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side effects induced by anti-parkinsonian therapy. Proc Natl Acad Sci 2009;106: 2892-2896.
     

  23. Yalçın Çakmaklı G, Oruçkaptan H, Saka E, Elibol B. Reversible acute cognitive dysfunction induced by bilateral STN stimulation.  J Neurol 2009; 256: 1360-1362.
     

  24. Saka E. Pathophysiology of Alzheimer’s disease: Experimental and genetic findings. Turkish Journal of Geriatrics 2010;13 (suppl 3): 21-26.
     

  25. Cantuti-Castelvetri I, Hernandez LF, Keller-McGandy CE, Kett LR, Landy A, Hollingsworth ZR, Saka E, Crittenden JR, Nillni EA, Young AB, Standaert DG, Graybiel AM. Levodopa-induced dyskinesia is associated with increased tyrotropin releasing hormone in dorsal striatum of hemi-parkinsonian rats. PLoS One. 2010; Nov 10;5 (11): e13861.
     

  26. Saka E, Topcuoglu MA, Demir AU, Elibol B. Transcranial sonography in Perry syndrome. Parkinsonism Relat Disord, 2010; 16: 68-70.
     

  27. Ertuğrul A, Ozdemir H, Vural A, Dalkara T, Meltzer HY, Saka E.  The influence of N-desmethyclozapine and clozapine on recognition memory and BDNF expression in hippocampus. Brain Res Bull 2011; 84(2):144-150.
     

  28. Celebi O, Temuçin CM, Elibol B, Saka E. Short latency afferent inhibition in Parkinson’s disease patients with dementia. Mov Disord 2012; 27(8):1052-1055.
     

  29. Ozdemir H, Ertugrul A, Basar K, Saka E. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice. Prog Neuropsychopharmacol Biol Psychiatry 2012;39(1): 62-68.
     

  30. Bekircan-Kurt CE, Temucin CM, Elibol B, Saka E. ‘Jaw clenching’ in anti-Ri –Antibody-associated paraneoplastic syndrome. Parkinsonism Relat Disord 2013; 19(1):132-133.
     

  31. Hacioglu G, Seval-Celik Y, Tanriover G, Ozsoy O, Saka-Topcuoglu E, Balkan S, Agar A. Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson’s disease. Folia Histochem Cytobiol 2012; 50(2): 228-238.
     

  32. Del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C. Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update. Biomark Med. 2012; 6(4):419-430.
     

  33. Agayeva N, Karli-Oguz K, Saka E. Teaching NeuroImages: a neurosyphilis case presenting with atypical neuroradiologic findings. Neurology 2013; 80(11):e119.
     

  34. Dericioglu N, Vural A, Acar P, Agayeva N, Ismailova V, Kurne A, Saka E, Arsava EM, Topcuoglu MA. Antiepileptic treatment for anti-NMDA receptor encephalitis: the need for video-EEG monitoring. Epileptic Disord. 2013;15(2):166-70.

  35. Celebi O, Temuçin ÇM, Elibol B, Saka E. Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy. Parkinsonism Relat Disord 2014; 20(6):632-6.
     

  36. Sag AT, Saka E, Ozgur TT, Sanal O, Ayvaz DC, Elibol B, Kurne AT. Progressive neurodegenerative syndrome in a patient with X-linked agammaglobulinemia receiving intravenous immunoglobulin therapy. Cogn Behav Neurol 2014; 27(3):155-9.
     

  37. Vural A, Acar NP, Soylemezoglu F, Oguz KK, Dericioğlu N, Saka E. Isolated central nervous system Whipple's disease: Two cases. Clin Neurol Neurosurg 2015 Aug 28;139:91-94. doi: 10.1016/j.clineuro.2015.08.028.
     

  38. Celebi O, Uzdogan A, Oguz KK, Has AC, Dolgun A, Cakmakli GY, Akbiyik F,  ElibolB, Saka E. Default mode network connectivity is linked to cognitive functioning and CSF Aβ(1-42) levels in Alzheimer's disease. Arch Gerontol Geriatr. 2016; 62:125-32.
     

  39. Ozisik L, Tanriover MD, Saka E. Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. Intern Med. 2016;55(10):1393-6.
     

  40. Erer S, Egeli U, Zarifoglu M, Tezcan G, Cecener G, Tunca B, Ak S, Demirdogen E, Kenangil G, Kaleagası H, Dogu O, Saka E, Elibol B. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations. Clin Neurol Neurosurg. 2016 Sep;148:147-53.
     

  41. Bekircan-Kurt CE, Güneş HN, Yildiz FG, Saka E, Tan E, Erdem-Özdamar S. New mutations and genotype-phenotype correlation in late-onset Pompe patients. Acta Neurol Belg. 2017 Mar;117(1):269-275.
     

  42. Olgiati S, Doğu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Sürmeli R, Sünter G, Doğan T, Yalçın AD, Bilgiç B, Elibol B, Emre M, Hanagasi HA, Bonifati V. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism Relat Disord. 2017 Mar 21. pii: S1353-8020(17)30107-4.
     

  43. Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G. Recommendations for cerebrospinal fluid Alzheimer's diseasebiomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimers Dement. 2017 Mar;13(3):285-295.
     

  44. Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimers Dement. 2017 Mar;13(3):274-284.
     

  45. Yildiz FG, Saka E, Elibol B, Temucin CM. Modulation of Cerebellar-Cortical Connections in Multiple System Atrophy Type C by Cerebellar Repetitive Transcranial Magnetic Stimulation. Neuromodulation. 2017 Mar 7.20.
     

  46. Onder H, Saka E. Post-stroke totally recovery of tremor in a patient with Parkinson's disease. Neurol Sci. 2017 Feb 24. doi: 10.1007/s10072-017-2869-x.
     

  47. van Waalwijk van Doorn LJ, Gispert JD, Kuiperij HB, Claassen JA, Arighi A, Baldeiras I, Blennow K, Bozzali M, Castelo-Branco M, Cavedo E, Emek-Savaş DD, Eren E, Eusebi P, Farotti L, Fenoglio C, Ormaechea JF, Freund-Levi Y, Frisoni GB, Galimberti D, Genc S, Greco V, Hampel H, Herukka SK, Liu Y, Lladó A, Lleó A, Nobili FM, Oguz KK, Parnetti L, Pereira J, Picco A, Pikkarainen M, de Oliveira CR, Saka E, Salvadori N, Sanchez-Valle R, Santana I, Scarpini E, Scheltens P, Soininen H, Tarducci R, Teunissen C, Tsolaki M, Urbani A, Vilaplana E, Visser PJ, Wallin AK, Yener G, Molinuevo JL, Meulenbroek O, Verbeek MM. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes. J Alzheimers Dis.2017;56(2):543-555.
     

  48. Eryilmaz IE, Cecener G, Erer S, Egeli U, Tunca B, Zarifoglu M, Elibol B, Bora Tokcaer A, Saka E, Demirkiran M, Akbostanci C, Dogu O, Colakoglu B, Kenangil G, Kaleagasi H. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions. Neurol Res. 2017 Aug 22:1-8. doi: 10.1080/01616412.2017.1368141.
     

  49. Topcuoglu MA, Saka E, Silverman SB, Schwamm LH, Singhal AB. Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors. JAMA Neurol. 2017 Sep 1;74(9):1048-1055.
     

  50. Onder H, Evren Erdener S, Saka E. Progressive anterior operculum syndrome due to frontotemporal lobar degeneration. Neurol Sci. 2018 Feb;39(2):385-387.
     

  51. Çakmakli GY, Vural A, Koçak EE, Elibol B, Saka E. Striatal Neurotransmitter Release-related Presynaptic Proteins in L-dopa Induced Dyskinesia in a Model of Parkinsonism. Noro Psikiyatr Ars. 2018 Mar 19;55(1):73-79.
     

  52. Büyükşerbetçi G, Saka E, Oğuz KK, Göçmen R, Arsava EM, Topçuoğlu MA. Cognitive Dysfunction in Relation to Topography and Burden of Cerebral Microbleeds. NoromPsikiyatr Ars. 2018 Mar 19;55(1):84-90.
     

  53. Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, Özkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut BÖ, Tüfekcioglu Z, Acarer A, Balaban H, Erer S, Dogu  Kibaroglu S, Aydin N, Hanagasi H, Elibol B, Emre M, Stebbins GT, Goetz CG. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2017 Nov 16;5(1):54-59. doi: 10.1002/mdc3.12556.
     

bottom of page